Drug-driven HRD: From Bench to Bedside & Back: Discovering Novel Biomarkers for PARP

Time: 9:30 am
day: Day Two

Details:

  • Understanding and utilizing drug-driven Homologous Recombination Deficiency (HRD)
  • Potentials and hope for a Rad51 biomarker
  • Furthering the understanding of primary and acquired resistance to PARP inhibitors

Speakers: